fda glp-1 compounding enforcement news october 2025 Compounded weight-loss and hormone drugs are booming, but experts say regulators have little visibility into who is taking them or what side effects they may be causing. ⁠ ⁠ Critics warn that Novo pressures GLP-1 compounders as

Transcriptional upregulation of c-MET is associated with invasion and tumor budding in colorectal cancer

10.3390/ijms23179826

Ive been trudging through a multitude of interrelated health and hormonal issues since I was a teen, and while Ive seen over 2 dozen doctors for these particular issues, nobody nobody

This systematic review of low-to-moderate evidence on the GLP-1 user risk of perioperative regurgitation and aspiration will examine the ongoing challenges in developing evidence-based clinical guidelines for patients using GLP-1 RAs, particularly with respect to perioperative management

doi: 10.1186/s13643-023-02238-w 37

Sign up here to get The Boston Globes latest food stories delivered to your inbox once a week